Hepatocellular Adenoma: What We Know, What We Do Not Know, and Why It Matters

2021 ◽  
Author(s):  
Paulette Bioulac‐Sage ◽  
Annette S.H. Gouw ◽  
Charles Balabaud ◽  
Christine Sempoux
Keyword(s):  
Hepatocellular Adenoma

Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison

2019 ◽  
Vol 119 ◽  
pp. 108633 ◽  
Author(s):  
Roberto Cannella ◽  
Giuseppe Brancatelli ◽  
Balasubramanya Rangaswamy ◽  
Marta I. Minervini ◽  
Amir A. Borhani ◽  
...  
Keyword(s):  
Mr Imaging ◽  
Contrast Agents ◽  
Hepatocellular Adenoma ◽  
Enhancement Pattern ◽  
Intraindividual Comparison

scholarly journals Multidisciplinary management of the pregnant patient in haemorrhagic shock secondary to an undiagnosed ruptured liver adenoma

2020 ◽  
Vol 13 (2) ◽  
pp. e231995
Author(s):  
Brittany Sanford ◽  
Catherine Hoeppner ◽  
Tammy Ju ◽  
Brian K Theisen ◽  
Anna BuAbbud ◽  
...  
Keyword(s):  
General Surgery ◽  
Case Reports ◽  
Hepatocellular Adenoma ◽  
Multidisciplinary Care ◽  
Exploratory Laparotomy ◽  
Pregnant Patient ◽  
Haemorrhagic Shock ◽  
Liver Adenoma ◽  
Life Threatening ◽  
Temporary Closure

Management of a ruptured hepatocellular adenoma during pregnancy is a rare and potentially life-threatening entity. Few case reports have described management of the pregnant patient who presents in haemorrhagic shock secondary to a ruptured liver adenoma. A 30-year-old primigravid woman at 31 weeks pregnant presented with abdominal pain and fetal bradycardia. After stat caesarean delivery of the infant, she had continued hemoperitoneum and was in shock secondary to an undiagnosed ruptured liver mass. General surgery was consulted intraoperatively and performed an exploratory laparotomy, packing and temporary closure. She was subsequently taken to interventional radiology (IR) for angioembolisation of the left hepatic artery. After stabilisation, she underwent formal abdominal closure. Management of a ruptured hepatocellular adenoma in pregnancy requires urgent multidisciplinary care including obstetrics gynaecology, general surgery and IR.

Serum Amyloid A-Positive Hepatocellular Neoplasm: A New Type of Tumor Arising in Patients with Advanced Alcoholic Disease

2015 ◽  
Vol 33 (5) ◽  
pp. 648-654 ◽  
Author(s):  
Motoko Sasaki ◽  
Yasuni Nakanuma
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Disease ◽  
Serum Amyloid A ◽  
Hepatocellular Adenoma ◽  
Clinicopathological Features ◽  
Serum Amyloid ◽  
Amyloid A ◽  
New Type ◽  
Strong Immunoreactivity ◽  
Alcoholic Disease

This chapter reviews a new type of hepatocellular neoplasm, serum amyloid A-positive hepatocellular neoplasm (SAA-HN), which arises in patients with advanced alcoholic liver disease such as cirrhosis. SAA-HNs share histological and immunohistochemical features with inflammatory hepatocellular adenoma, for example, a strong immunoreactivity for SAA. Clinicopathological features and issues regarding SAA-HN are reviewed with emphasis regarding its potential to develop into hepatocellular carcinoma.

Establishment and Characterization of a Nontumorigenic Cell Line Derived from a Human Hepatocellular Adenoma Expressing Hepatocyte-Specific Markers

1997 ◽  
Vol 236 (2) ◽  
pp. 418-426 ◽  
Author(s):  
Claudia Schleger ◽  
Rosario Heck ◽  
Fataneh Niketeghad ◽  
Peter Schirmacher ◽  
Svetlana Radaeva ◽  
...  
Keyword(s):  
Cell Line ◽  
Hepatocellular Adenoma

scholarly journals PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs

PPAR Research ◽  
2012 ◽  
Vol 2012 ◽  
pp. 1-16 ◽  
Author(s):  
Marion Peyrou ◽  
Pierluigi Ramadori ◽  
Lucie Bourgoin ◽  
Michelangelo Foti
Keyword(s):  
Liver Diseases ◽  
Metabolic Diseases ◽  
Viral Infections ◽  
Inflammatory Responses ◽  
Current Knowledge ◽  
Hepatocellular Adenoma ◽  
Peroxisome Proliferator ◽  
Cancer Therapies ◽  
Ppar Agonists ◽  
Expression And Activity

Peroxisome-proliferator-activated receptors (PPARs) are ligand-activated nuclear receptors that exert in the liver a transcriptional activity regulating a whole spectrum of physiological functions, including cholesterol and bile acid homeostasis, lipid/glucose metabolism, inflammatory responses, regenerative mechanisms, and cell differentiation/proliferation. Dysregulations of the expression, or activity, of specific PPAR isoforms in the liver are therefore believed to represent critical mechanisms contributing to the development of hepatic metabolic diseases, disorders induced by hepatic viral infections, and hepatocellular adenoma and carcinoma. In this regard, specific PPAR agonists have proven to be useful to treat these metabolic diseases, but for cancer therapies, the use of PPAR agonists is still debated. Interestingly, in addition to previously described mechanisms regulating PPARs expression and activity, microRNAs are emerging as new important regulators of PPAR expression and activity in pathophysiological conditions and therefore may represent future therapeutic targets to treat hepatic metabolic disorders and cancers. Here, we reviewed the current knowledge about the general roles of the different PPAR isoforms in common chronic metabolic and infectious liver diseases, as well as in the development of hepatic cancers. Recent works highlighting the regulation of PPARs by microRNAs in both physiological and pathological situations with a focus on the liver are also discussed.

Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia

2018 ◽  
Vol 49 (3) ◽  
pp. 700-710 ◽  
Author(s):  
Inge J.S.M.L. Vanhooymissen ◽  
Maarten G. Thomeer ◽  
Loes M.M. Braun ◽  
Bibiche Gest ◽  
Sebastiaan van Koeverden ◽  
...  
Keyword(s):  
Focal Nodular Hyperplasia ◽  
Hepatocellular Adenoma ◽  
Hepatobiliary Phase ◽  
Nodular Hyperplasia

scholarly journals Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency

2019 ◽  
Vol 2019 ◽  
pp. 1-6 ◽  
Author(s):  
Lin Cheng ◽  
Yajuan Liu ◽  
Wenjing Wang ◽  
J. L. Merritt ◽  
Matthew Yeh
Keyword(s):  
Liver Damage ◽  
English Language ◽  
Scientific Literature ◽  
Hepatocellular Adenoma ◽  
Ornithine Transcarbamylase ◽  
Ornithine Transcarbamylase Deficiency ◽  
Otc Deficiency

Ornithine transcarbamylase (OTC) deficiency is an X-linked recessive disorder that leads to hyperammonemia and liver damage. Hepatocellular adenoma in OTC deficiency patients has not been previously described. Here we report the first such case to be described in the English language scientific literature.

Sign in / Sign up

Export Citation Format

Share Document